Global adaptation to a lipid environment triggers the dormancy- related phenotype of mycobacterium tuberculosis by Rodríguez, Juan G. et al.
Global Adaptation to a Lipid Environment Triggers the Dormancy-
Related Phenotype of Mycobacterium tuberculosis
Juan G. Rodríguez,a Adriana C. Hernández,a Cecilia Helguera-Repetto,b Diana Aguilar Ayala,b Rosalina Guadarrama-Medina,b
Juan M. Anzóla,a Jose R. Bustos,a María M. Zambrano,a Jorge González-y-Merchand,b María J. García,c Patricia Del Portilloa
Departamento de Biotecnología Molecular y Genética Molecular, Corporación CorpoGen, Bogotá, Colombiaa; Escuela Nacional de Ciencias Biológicas, Instituto
Politécnico Nacional (IPN), Mexico Distrito Federalb; Departamento de Medicina Preventiva, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spainc
ABSTRACT Strong evidence supports the idea that fatty acids rather than carbohydrates are the main energy source of Mycobacte-
rium tuberculosis during infection and latency. Despite that important role, a complete scenario of the bacterium’s metabolism
when lipids are the main energy source is still lacking. Here we report the development of an in vitro model to analyze adapta-
tion of M. tuberculosis during assimilation of long-chain fatty acids as sole carbon sources. The global lipid transcriptome re-
vealed a shift toward the glyoxylate cycle, the overexpression of main regulators whiB3, dosR, and Rv0081, and the increased ex-
pression of several genes related to reductive stress. Our evidence showed that lipid storage seems to be the selected mechanism
used by M. tuberculosis to ameliorate the assumed damage of reductive stress and that concomitantly the bacilli acquired a
slowed-growth and drug-tolerant phenotype, all characteristics previously associated with the dormant stage. Additionally, in-
tergenic regions were also detected, including the unexpected upregulation of tRNAs that suggest a new role for these molecules
in the acquisition of a drug-tolerant phenotype by dormant bacilli. Finally, a set of lipid signature genes for the adaptation pro-
cess was also identified. This in vitro model represents a suitable condition to illustrate the participation of reductive stress in
drugs’ activity against dormant bacilli, an aspect scarcely investigated to date. This approach provides a new perspective to the
understanding of latent infection and suggests the participation of previously undetected molecules.
IMPORTANCE Mycobacterium tuberculosis establishes long-lasting highly prevalent infection inside the human body, called latent
tuberculosis. The known involvement of fatty acids is changing our understanding of that silent infection; however, question of
how tubercle bacilli globally adapt to a lipid-enriched environment is still an unanswered. With the single change of providing
fatty acids as carbon sources, the bacilli switch on their program related to dormant stage: slowed growth, accumulation of lipid
bodies, and development of drug tolerance. In this stage, unexpected and previously unknown participants were found to play
putatively important roles during the process. For the first time, this work compares the global transcriptomics of bacteria by
using strand-specific RNA sequencing under two different growth conditions. This study suggests novel targets for the control of
tuberculosis and provides a new straightforward in vitro model that could help to test the activity of drugs against dormant ba-
cilli from a novel perspective.
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It is estimated that 2 billion people are latently infected withMycobacterium tuberculosis, representing potential cases of reac-
tivation and transmission and hampering better control of the
disease (1). As tuberculosis (TB) infection progresses, the bacilli
face adverse environmental conditions to which they respond by
entering into a silent phase known as dormancy. In this phase, the
bacteria are able to survive for the entire life of the host causing
latent infection. Eventually, they can also reactivate and cause ac-
tive disease when the host’s immune system becomes weakened
(2). Bacterial adaptation to the different stages of the infection
involves fine regulation of gene expression. Global transcriptome
analysis has identified critical regulators of gene expression such as
the phoP virulence regulator (3), the kstR cholesterol regulator (4),
the dosR hypoxia regulator (5), or Rv0081, which was also recently
proposed as a hypoxia regulator (6). The identification of noncod-
ing RNAs in M. tuberculosis also suggests that these molecules
could regulate microbial adaptation (7, 8). During latency, M. tu-
berculosis is presumed to reside in lipid-rich foamy macrophages
(9) and accumulate internal lipid droplets full of triacylglycerols
(TAGs) that are used subsequently as an energy source for persis-
tence (10). Nevertheless, the bacilli continue replication (11) and
retain low but detectable metabolic activity (12). It has also been
shown that M. tuberculosis uses host lipids, in particular, fatty
acids and cholesterol, as energy sources during intracellular
growth and persistence (13–15).
Although several in vitro models have been used to mimic the
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environment of dormant bacilli during latency (16–18), cultures
grown in the presence of lipids, the most abundant molecules
surrounding bacilli in vivo, have not been extensively analyzed.
To gain insight into the process ofM. tuberculosis adaptation to
a fatty acid environment, we developed an in vitro model where
bacilli were grown in even-length long-chain fatty acids (LC-FAs)
as the sole carbon source. Even-length LC-FAs were selected be-
cause they are the main LC-FAs found in human cells (19) and are
a major component of TAGs (20). Although other in vivo lipid
energy sources cannot be ignored, it is possible that for long-term
infection, bacilli might benefit by selecting even-length LC-FAs,
avoiding the toxicity associated with other lipid sources (21).
We analyzed changes in the global transcriptome of M. tuber-
culosis by using high-throughput methods such as strand-specific
RNA sequencing (ss-RNA-seq) (22).
RESULTS AND DISCUSSION
The global transcriptome of M. tuberculosis in the LC-FA in
vitro model. In order to mimic the nutrient conditions presumed
to be encountered by M. tuberculosis during in vivo infection (23),
we cultured M. tuberculosis H37Rv in a medium supplemented
with a mixture of even-length LC-FAs as the sole carbon source.
Growth in LC-FAs was compared to growth in dextrose as a con-
trol. We found that growth in LC-FAs was slower than growth in
dextrose but reached similar saturation points (see Fig. S1 in the
supplemental material).
RNA was analyzed by ss-RNA-seq with material from bacilli
grown in dextrose to the exponential (DE) and stationary (DS)
phases and in LC-FA to the exponential (FE) and stationary (FS)
phases (see Fig. S1). The sequence depth obtained showed good
coverage of the M. tuberculosis genome, as indicated by the pla-
teaus reached in all instances by mapping reads against coding
sequences (CDS) (see Fig. S2A). A normal distribution of the data
was achieved in all cases (see Fig. S2B) (24). The number of se-
quences retained after processing for quality was 13.1 to 19.3 mil-
lion reads (Table 1). To facilitate the comparison of gene expres-
sion, the data were normalized as reads per kilobase per million
reads (RPKM). Only genes showing 1 RPKM were considered
for analysis. Statistical analysis for significant differential gene ex-
pression was performed with Fisher exact test (see Table S1A and
B in the supplemental material). That analysis gave results consis-
tent with those obtained with the DEGseq package for biological
replicates (see Table S1C and D) (see Materials and Methods).
We identified all 45 tRNAs (25) (see Table S2A), all of the most
highly expressed small RNAs (7), and most of the previously iden-
tified noncoding RNAs (8) (see Table S2B). During growth in
LC-FAs, gene expression (reads mapped to CDS) was greatly re-
duced compared with the control, particularly in the stationary
phase (Table 1). This low gene expression contrasts with the high
number of reads that mapped to intergenic regions (IGRs), sug-
gesting close control mediated by small RNAs in cultures grown
with LC-FAs.
Consistent with the high number of reads mapping to IGRs in
the FS culture, the four most highly expressed IGRs corresponded
to this sample (see Table S2B and C). Two of them, namely,
MTS2823 and MTS0977 (see Table S2C), have also shown in-
creased expression during infection (7), suggesting that they
might be important regulators and highlighting the association of
the conditions used in our model with the conditions encountered
by the bacilli in vivo.
More remarkable was the overexpression of tRNAs in FS (see
Table S2A), which contrasts with the few transcripts mapped to
CDS in FS and which, presumably, was a reflection of low trans-
lation activity (Table 1). Aminoacyl tRNAs are involved in cellular
processes other than protein synthesis, such as the modification of
bacterial membrane lipids via the multiple-peptide resistance fac-
tor (MprF) protein (26). MprF attaches positively charged amino
acids to the polar heads of phosphatidylglycerol, effectively neu-
tralizing the negative charge of the membrane (27) and thus de-
creasing membrane permeability and susceptibility to antibacte-
rial peptides and cationic antibiotics (28). The tRNAs involved in
these changes are tRNA-Lys, tRNA-Ala, and less frequently tRNA-
Arg (26, 29), the same tRNAs that were expressed more in FS than
in DS in our model (Fig. 1). We hypothesize that, in the presence
of FA, bacilli modify their envelope by aminoacyl-tRNAs, confer-
ring adaptation to stress and possibly increasing tolerance to an-
tibiotics, a process associated with the dormant stage of M. tuber-
culosis (17). Whether this attractive mechanism to modify the cell
envelope is, in fact, involved in the adaptation and survival of the
bacilli during long-term infection remains to be investigated.
Comparative analysis of CDS between growth in dextrose and
LC-FA showed that majority of genes had similar expression lev-
els, both at exponential and stationary phases (see Fig. S3A and B
in the supplemental material), with only 10% of the potential CDS
being differentially expressed (Fig. 2; see Table S3). This analysis
identified genes with differential expression in all of the functional
categories of TubercuList (http://www.tuberculist.epfl.ch), with
the exception of genes belonging to the PE/PPE category in the
exponential phase (Fig. 2; see Table S3). On the contrary, the
PE/PPE category was overrepresented in the stationary phase
(Fig. 2 and Table S3), suggesting that when M. tuberculosis grows
in a fatty acid environment, these abundant proteins (25) might
TABLE 1 Transcriptomic profile of M. tuberculosis in different carbon sourcesa
Reads
No. (%) of reads in following growth phase:
DE DS FE FS
All 13.12 19.29 18.314 16.054
All mapped 8.17 (62.3) 10.78 (55.9) 9.56 (53.4) 8.01 (51.2)
Mapped without rRNA
Mapped to CDS 0.52 (71.3) 0.51 (57.6) 0.28 (61.6) 0.10 (13.4)
Mapped to IGRs 0.17 (22.4) 0.25 (28.0) 0.149 (32.9) 0.62 (83.0)
Mapped to antisense CDS 0.05 (6.4) 0.13 (14.4) 0.02 (5.4) 0.03 (3.6)
a Total numbers (in millions) of reads determined under the different conditions tested (upper part) and numbers (percentages) of reads determined by excluding those
corresponding to rRNA (lower part) are shown.
Rodríguez et al.
2 ® mbio.asm.org May/June 2014 Volume 5 Issue 3 e01125-14
 
m
bio.asm
.org
 o
n
 O
ctober 28, 2014 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
play an additional role in antigenic variation and immune evasion
(30, 31). Contrary to our expectations, genes belonging to the
functional category “lipid metabolism” were not overrepresented
in either the exponential or the stationary phase (Fig. 2; see Ta-
ble S3), a result that could be attributed to the gene redundancy
present within this category (25). Among the most highly differ-
entially expressed genes in FS, we identified pckA (P 414) and
tgs-1 (P 213) (see Table S1F), both of which play critical roles in
the lipid metabolic pathways of M. tuberculosis (10, 32). As hap-
pens with pckA, the gene icl-1 was also upregulated within the
trichloroacetic acid (TCA) cycle (see Table S1E and F), consistent
with the central role of these enzymes in M. tuberculosis lipid me-
tabolism (13). Because of the use of only even-length LC-FAs, we
did not expect production of propionyl coenzyme A (CoA) from
lipid degradation. In agreement with this, we did not detect in-
creased expression of genes belonging to the methylcitrate and
methylmalonate pathways (33).
The functional category of “regulatory proteins” was under-
represented in the stationary phase, highlighting the involvement
of four genes upregulated in the same phase (FS) (Fig. 2; see Ta-
ble S3). Two of these correspond to the known regulators WhiB3,
which is associated with redox balance (34), and DosR, which is
related to redox balance, and a major regulator of hypoxia in
M. tuberculosis (5). As a result, a large number of DosR-regulated
genes were also expressed more in FS than in DS (Table 2; see
Table S1F). We also identified the recently reported regulator
Rv0081, which is considered a global hypoxic response regulator
(6) and the presumptive transcriptional regulator nrdR (http:
//www.tuberculist.epfl.ch).
Given that WhiB3 and DosR, two heme sensor proteins related
to intracellular redox balance (34, 35), were identified as key com-
ponents of the adaptation of M. tuberculosis to growth in LC-FA,
we searched for significantly overexpressed genes involved in re-
dox balance. Independently of the phase of growth, bacilli cul-
tured in LC-FAs had a higher percentage of significantly overex-
pressed genes associated with reductive stress (see Table S4A).
These results suggest that growing M. tu-
berculosis in a fatty acid medium puta-
tively causes a burst in reductive stress
and thus the required molecules to main-
tain redox balance would be induced in
order to allow cell growth under these
conditions. An imbalance of the redox
equilibrium leads to either reductive or
oxidative stress responses, the latter well
documented to be involved in M. tuber-
culosis infection (36). However, the con-
tribution of its counterpart, namely, re-
ductive stress, has barely been considered
thus far and occurs when reducing equiv-
alents, such as NADH, FADH, or NA-
DPH, are abnormally increased (34, 37).
In our LC-FA cultures, the reducing
equivalents that could be generated by
both -oxidation of LC-FAs and TCA
metabolic activities would result in re-
ductive stress that must be cleared for
survival via reductive sinks, such as poly-
FIG 1 Differential expression of tRNAs in the fatty acid model. Fold change comparison of tRNAs between the stationary and exponential phases under both
culture conditions. Fold changes were calculated by calculating DS/DE (black bars) and FS/FE (light brown bars) RPKM ratios.
FIG 2 Genes differentially expressed in the fatty acid model. Numbers of genes differentially expressed
by functional categories according to TubercuList (http://www.tuberculist.epfl.ch/) are shown. Circle
sizes correspond to the numbers of genes with significant differential expression in fatty acid medium
versus dextrose medium. (A) Exponential phase. (B) Stationary phase.
RNA-seq of M. tuberculosis in a Fatty Acid Environment
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mer deposition, reverse TCA, or nitrate reductase activity, among
others (35, 37). The induced expression of 11 genes with allegedly
reductive sink activity, 8 of which are involved in polymer depo-
sition, might indicate the participation of reductive stress during
growth of M. tuberculosis in LC-FA (Table 3). Our results suggest
that polymer deposition, which includes TAG accumulation, as
well as the formation of other complex lipids, such as SL-1, PAT,
DAT, and PDIM (Table 3), was the main reductive sink mecha-
nism used by M. tuberculosis when grown on fatty acids as carbon
sources. This is consistent with the observed lipid droplets inside
M. tuberculosis during the stationary phase of growth in LC-FA
medium (Fig. 3A) and agrees with the suggestion that lipid accu-
mulation could be a reputed marker of M. tuberculosis during
latent infection (17, 38). The accumulation of lipid droplets inside
M. tuberculosis in our LC-FA in vitromodel, together with the high
expression of tgs-1, prompted us to test for drug tolerance, an-
other dormancy-related characteristic of the bacilli. To do this, we
determined the drug susceptibility of M. tuberculosis to a mixture
of four drugs known to be active against replicating and nonrep-
licating bacilli (39). Our results showed that M. tuberculosis man-
ifested greater drug tolerance in the presence of lipids than during
growth in dextrose (Fig. 3B and 3C). The relationship between the
detected overexpression of tRNAs and drug tolerance deserves
further investigation, as it represents an attractive idea regarding
the participation of tRNAs in the dormant stage ofM. tuberculosis.
Comparison of the LC-FA model with other dormancy-
related in vitro models. The host environmental cues that trigger
the M. tuberculosis dormant stage or long-term infection are not
fully elucidated, although changes associated with hypoxia, star-
vation, and low pH have been shown to be important (17). To test
the suitability of growth in LC-FA as an in vitro model, we com-
pared the gene expression profile of our lipid-enriched condition
with other well-established in vitro models designed to mimic the
hypoxic and starvation conditions faced by the pathogen within
the host. Genes with significantly higher expression during growth
in LC-FAs (see Table S1E and F in the supplemental material)
were compared with the highest-scoring genes derived from array
data obtained from the meta-analysis published by Murphy and
Brown (40). The total number of genes shared by any two condi-
tions was very similar, with no significant differences in percent-
ages (see Fig. S4A). Therefore, growth in LC-FA can be another
suitable in vitro model for the analysis of genes related to the dor-
TABLE 2 Member genes of the dormancy regulon with significantly increased expression in the fatty acid model
Gene tag
Gene
name
Functional
categorya Function (reference)
RPKM ratiob P valuec
FE/DE FS/DS FE vs DE FS vs DS
Rv0079 10 Unknown; probable transduction regulatory
protein (42)
1.59 2.10 1.09 E-12 3.37 E-07
Rv0080 10 —d 9.00 — 1.19 E-09
Rv0081 9 Global regulator in hypoxia — 1.10 — 0.014
Rv0243 fadA2 1 Lipid degradation — 1.60 — 9.87 E-05
Rv0569 10 — 3.07 — 0.90 E-14
Rv0570 nrdZ 2 Ribonucleoside-diphosphate reductase — 2.67 — 0.004
Rv1436 gap 7 1.15 — 0.028 —
Rv1652 argC 7 Arginine biosynthesis — 3.00 — 8.33 E-05
Rv1733c 3 Unknown; probable conserved transmembrane
protein
2.77 1.50 2.62 E-08 0.012
Rv1738 10 — 1.15 — 0.90 E-14
Rv1813c 10 3.53 — 1.09 E-12 —
Rv1996 0 Unknown; universal stress family protein 1.93 1.19 1.09 E-12 6.27 E-06
Rv2005c 0 Unknown; universal stress family protein — 6.50 — 3.15 E-13
Rv2007c fdxA 7 Ferredoxin FdxA — 2,18 — 1.09 E-12
Rv2030c 10 — 5.25 — 3.88 E-10
Rv2031c hspX 0 Stress protein induced in hypoxia — 6.05 — 0.90 E-14
Rv2623 TB31.7 0 Unknown; universal stress family protein — 3.08 — 0.90 E-14
Rv2625c 3 Unknown; probable conserved transmembrane
protein
— 3.20 — 1.44 E-06
Rv2626c hrp-1 10 — 4.67 — 0.90 E-14
Rv2627c 10 — 2.43 — 2.96 E-06
Rv2628 10 — 1.40 — 1.18 E-05
Rv2629 10 — 1.13 — 4.16 E-08
Rv3127 10 — 1.33 — 0.003
Rv3130c tgs-1 1 TAG — 2.31 — 2.07 E-13
Rv3131 10 Unknown; putative NAD(P)H nitroreductase 2.89 4.00 1.09 E-12 9.04 E-13
Rv3133c devR 9 Regulator part of the Dos TCSe — 2.60 — 6.54 E-05
Rv3134c 0 Unknown; universal stress protein family 1.03 3.43 5.99 E-06 3.19 E-10
a Functional categories based on http://www.tuberculist.epfl.ch: 0, virulence, detoxification, and adaptation; 1, lipid metabolism; 2, information pathways; 3, cell wall and cell pro-
cesses; 7, intermediary metabolism and respiration; 9, regulatory proteins; 10, conserved hypothetical proteins.
b RPKM ratio according to phase of growth: exponential (FE/DE) or stationary (FS/DS). See Table S1A and B in the supplemental material for the complete set of data. The gene is
overexpressed in FE or FS if the ratio is above 1.
c Determined by Fisher exact test, in which statistically significant differential expression between two conditions was determined by looking at genes with FDRs of0.05 (see
Materials and Methods for details).
d —, gene with a ratio of1 or with no significantly increased expression under those conditions.
e TCS, two-component regulatory system.
Rodríguez et al.
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mant stage of M. tuberculosis. It is noteworthy that growth in LC-
FAs and growth under hypoxia conditions shared more genes be-
longing to the DosR regulon than either condition compared to
growth during starvation (see Fig. S4A). Interestingly, one of the
LC-FAs used was palmitate, a fatty acid present in the culture
medium used in one of the classical in vitro models of persistence
(41).
Because of the suggested involvement of reductive stress in the
growth of M. tuberculosis in a lipid-enriched medium, we sought
to identify genes related to reductive stress in the same hypoxia
and starvation data set used for the above analysis (40). Of the 371
genes associated with reductive stress in the M. tuberculosis ge-
nome (http://www.tuberculist.epfl.ch), we excluded genes be-
longing to the functional category of “lipid metabolism” to avoid
bias toward the fatty acid model. We compared the remaining 216
genes with the 206 highest-scoring genes for all three data sets (see
Fig. S4B). The number of genes related to reductive stress identi-
fied in each case was different, with the highest represented by
LC-FA (24/206 genes, 11.1%), followed by hypoxia (14/206 genes,
6.5%), and the lowest represented by starvation (7/206 genes,
3.2%). The differences among percentages were close to signifi-
cant between hypoxia and LC-FA and clearly significant between
starvation and LC-FA (see Fig. S4B). Recently, it has been shown
that reductive stress could play a role during long-term mycobac-
terial infection and that lipids could be stakeholders in this process
(37). Our results also indicate that growth in LC-FAs might be a
more suitable in vitro model to better test the putative involve-
ment of reductive stress during the long-term infection of M. tu-
berculosis.
Genes involved in the adaptation of M. tuberculosis to a lipid
environment. The global analysis of the M. tuberculosis transcrip-
tome showed increased expression of genes involved in various
metabolic processes and identified specific genes that provide in-
sight into cellular adaptation during growth with fatty acids as the
sole carbon sources (Fig. 2; see Table S1E and F). Searching for a
set of genes related to the pathways used by M. tuberculosis to
adapt to a lipid environment, we identified 14 genes that had sig-
nificantly increased expression in FE and FS than in DE and DS,
respectively (Table 4) (42, 43). These genes therefore character-
ized the adaptation of the bacilli to growth in LC-FA medium and
thus provide a lipid signature for M. tuberculosis; this overexpres-
sion was confirmed by quantitative reverse transcription (qRT)-
PCR (see Fig. S5).
Several of these lipid signature genes are involved in cellular
intermediary metabolism. This includes the genes pckA and icl,
indicating that bacteria are actively using the glyoxylate shunt,
consistent with the central role of these enzymes inM. tuberculosis
lipid metabolism (13, 32). The gene pckA is required for growth in
fatty acids, and mutants defective in pckA are attenuated in both
macrophage and mouse infections (32). Moreover, icl and pckA
TABLE 3 Genes with significantly increased expression and their putative relation to reductive stress
Gene tag
Gene
name
Growth
phase
Functional
categoryb Function
Putative influence
on reductive stressc
RPKM
ratiod P valuee
Rv0243a fadA2 FS 1 Lipid degradation 1.60 9.87 E-05
Rv0570a nrdZ FS 2 Ribonucleoside-diphosphate reductase NADH/NADPH 2.67 0.004
Rv0694 lldD1 FE 7 L-Lactate dehydrogenase 1.09 0.029
Rv0697 FE 7 Unknown; probable dehydrogenase 4.33 0.001
Rv1180 pks-3 FE 1 Probable polyketide synthase Polymer deposition 3.20 5.9 E-04
Rv1436a gap FE 7 Probable GADPHf NADH 1.15 0.028
Rv1652a argC FS 7 Arginine biosynthesis NADH/NADPH 3.00 8.33 E-05
Rv1908c katG FE 0 Catalase/peroxidase 1.57 0.004
Rv2382c mbtC FE 1 Polyketide synthase Polymer deposition 4.00 0.032
Rv2590 fadD9 FE 1 Lipid degradation NADH/NADPH 3.71 5.68 E-07
Rv2781 FE 7 Oxidoreductase 3.80 1.94 E-10
Rv2794c pptT FE 1 4=-Phosphopantetheinyl transferase Polymer deposition 1.18 0.041
FS 3.00 8.33 E-05
Rv2931 ppsA FS 1 PDIM biosynthesis Polymer deposition 2.00 0.041
Rv2995c leuB FS 7 Leucine synthesis NADH/NADPH 2.60 6.54 E-05
Rv2996c serA1 FS 7 L-Serine synthesis NADH/NADPH 3.00 0.019
Rv3130ca tgs-1 FS 1 TAG synthase Polymer deposition 2.31 2.07 E-13
Rv3131a FE 10 Unknown Reductant collector 2.89 1.09 E-12
FS Putative NAD(P)H nitroreductase 4.00 9.04 E-13
Rv3145 nuoA FE 7 Probable NADH-dehydrogenase Reductant collector 1.03 0.008
Rv3229c desA3 FE 1 Lipid desaturase Polymer deposition 3.80 1.09 E-12
Rv3230 FE 7 Oxidoreductase 1.32 0.006
Rv3371 FS 1 TAG synthesis Polymer deposition 2.00 0.041
Rv3825c pks-2 FE 1 Probable polyketide synthase Polymer deposition 1.27 1.34 E-04
a Member of the DosR regulon.
b Functional categories based on http://www.tuberculist.epfl.ch: 0, virulence, detoxification, and adaptation; 1, lipid metabolism; 2, information pathways; 7, intermediary metabo-
lism and respiration; 10, conserved hypothetical proteins.
c RPKM ratio according to phase of growth: exponential (FE/DE) or stationary (FS/DS). The gene is overexpressed in FE or FS if the ratio is1. See Table S1A and B in the
supplemental material for the complete set of data.
d Arrows indicate the putative contributions of genes to the increase (up arrow) or decrease (down arrow) in reductive equivalents. Absence of an arrow indicates a gene that could
contribute to both an increase and a decrease in reductive equivalents, for example, an oxidoreductase-encoding gene.
e Determined by Fisher exact test, in which statistically significant differential expression between two conditions was determined by looking at genes with FDRs of0.05 (see
Materials and Methods for details).
f GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
RNA-seq of M. tuberculosis in a Fatty Acid Environment
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are also upregulated in nongrowing bacilli in murine models (13,
15).
Two lipid signature genes belong to the functional category of
“lipid metabolism” (http://www.tuberculist.epfl.ch): Rv1184,
which codes for an exported protein that is able to perform lipid
degradation and pptT, which encodes a phosphopantetheinyl
transferase that activates the polyketide synthases (44). Two addi-
tional genes are related to membrane activity allegedly involved in
either the transport of metabolites (Rv1733) or associated with the
ESX-1 secretion system of M. tuberculosis (Rv3614c), the latter
coding for EspD.
WhiB3 was the single transcriptional regulator detected as part
of the signature. This heme-based sensor, which is associated with
intracellular redox balance, links environmental signaling with
cellular metabolism (34). Interestingly, five of the members of the
lipid signature belong to the DosR hypoxia regulon. This suggests
that induction of the DosR transcriptional regulator could result
from cotranscription from the upstream Rv3134c gene (45, 46),
which is part of the lipid signature. The Rv3134c gene harbors a
usp domain, as does another gene of the lipid signature, Rv1996.
One of the DosR-regulated genes, Rv0079c, has recently been re-
ported as a dormancy-associated translation inhibitor (DATIN)
that inhibits in vitro protein synthesis. Overexpression of a recom-
binant DATIN in Escherichia coli and inMycobacterium bovisBCG
decreased the growth rate of these microorganisms (42). We
therefore suggest that the overexpression of this gene in both the
exponential and stationary phases could be the responsible for the
observed slower growth of M. tuberculosis in LC-FA (see Fig. S1 in
the supplemental material). Many of the genes included in the
lipid signature are of unknown function, showing our scarce
knowledge of how M. tuberculosis adapts to a lipid-enriched con-
dition. One of these genes, Rv1733c, codes for a hypothetical pro-
tein reported to be induced by hypoxia and starvation (5).
To investigate whether these genes could be coregulated at the
transcriptional level, we searched for a possible consensus motif
500 nucleotides (nt) upstream of each open reading frame (ORF)
(47). We identified a DNA motif in 12 of the 14 genes analyzed
(Fig. 4). The probability that this motif could be present in these
genes by chance was 1E-07, thus suggesting a biological function
of the motif in genes of the lipid signature. Interestingly, the motif
was not found upstream ofwhiB3, opening the possibility that this
gene product could be involved in transcriptional regulation of
the lipid signature genes. The identification of an antisense tran-
script of the whiB3 gene in DS (Fig. 4B.2) strongly suggests the
FIG 3 Dormancy-related phenotype ofM. tuberculosis grown in the fatty-acid model. (A) Electron micrographs ofM. tuberculosis grown under different carbon
sources. White arrows indicate presumed lipid bodies identified in LC-FA at stationary phase. Magnification: 60,000 (DE, DS, and FE) or 12,000 (FS).
Exponential- and stationary-phase cultures were incubated with drugs in the presence of dextrose or fatty acids. Cultures were collected after 7, 14, or 21 days of
exposure to drugs as estimated by CFU counting (B) or by calculating the MPN/ml (C) (see Materials and Methods for details). The R, MX, MZ, and AK
concentrations used were 8, 4, 8, and 8 g/ml, respectively. Means and standard deviations of four experiments are shown.
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involvement of noncoding RNA in whiB3 gene regulation under
lipid-enriched conditions.
To assess the relevance of these genes for M. tuberculosis
growth, we next compared this list with previously reported stud-
ies aimed at identifying essential genes. Interestingly, none of the
14 lipid signature genes were found to contain IS6110 insertions in
the in vivo survey of 533 isolates worldwide, with the exception of
Rv1733, which had an IS6110 insertion in 2 of the 533 isolates
analyzed (48). In contrast, 10 of the 14 genes are considered non-
essential for in vitro M. tuberculosis growth, based on transposon
mutagenesis (49). These data support our proposal that the
LC-FA model could be more closely related to the conditions that
the bacilli confront in vivo during TB infection.
Final remarks. On the basis of the results presented here, we
propose the following scenario for M. tuberculosis growing on
even-length LC-FAs (Fig. 5). Lipids surrounding the bacilli, TAG
or LC-FAs, are hydrolyzed by lipases (such as Rv1184) and then
internalized through receptors (Rv1733c). The lipids are subse-
quently converted to acetyl-CoA by -oxidation and consumed
by the glyoxylate cycle (Icl1). At this point, PckA can regenerate
phosphoenolpyruvate to continue the cycle. As a consequence,
both CO2 and the reducing equivalents NADH and NADPH in-
crease and are sensed by the DosR, Rv0081, and WhiB3 transcrip-
tional regulators. These and probably other stress conditions in-
duce the expression of genes such as pptT, pks-2, pks-3, and tgs-1,
which are responsible for the synthesis of complex lipids that bal-
ance the redox state of the cell by polymer deposition. The detec-
tion of espD suggests secretion, possibly of toxic compounds. On
the other hand, several genes of the DosR regulon are induced:
stress proteins (Rv1996, and Rv3134c, which are cotranscribed
with dosR) and other reductive sinks (Rv3131), inhibitors of pro-
tein synthesis (Rv0079), and heme stabilization proteins (fdxA).
Proteins required for porphyrin synthesis (HemA and HemC) are
also induced (see Table S4B). Finally, the high expression of
tRNAs could modify membrane properties, resulting in tolerance
to environmental stresses and antibiotics. We propose that when
M. tuberculosis grows on LC-FAs as sole carbon sources, the cells
change their gene expression profile by inducing genes required
for stress protection, as well as genes required for its survival dur-
ing long-term infection. Our results therefore provide insight into
the physiological responses of tubercle bacilli when grown in a
lipid-rich environment, a poorly studied aspect of TB infection.
Studying the metabolic activity of M. tuberculosis during latent
infection is not an easy task (50). TB was recently described as a
continuum, from active disease to latent infection, and the accu-
mulation of data indicates that latency might not be considered a
single condition either (50). Although it is still unclear, it appears
that dormant bacilli include cells with different metabolic activi-
ties, from slowly growing to nondividing stages that vary in terms
of redox balance and require responses to oxidative stress or re-
ductive stress, balanced by the cooperation of main regulators,
such as WhiB3, DosR, and the recently identified Rv0081 (6). The
development of new drugs against dormant bacilli has been diffi-
cult probably because of our poor knowledge of real metabolic
TABLE 4 Lipid signature of M. tuberculosis grown in the fatty acid model
Gene tag
Gene
name
Functional
categoryb Function (reference)
RPKM ratioc P valued
FE/DE FS/DS FE vs DE FS vs DS
Rv0079a 10 Unknown; probable transduction
regulatory protein (42)
1.59 2.10 01.09 E-12 3.37 E-07
Rv0211 pckA 7 Phosphoenolpyruvate carboxykinase 1.03 1.83 0.021 4.03 E-14
Rv0467 icl-1 7 Isocitrate lyase 3.88 1.52 1.58 E-08 3.89 E-09
Rv1066 10 Unknown; rhodanase like domaine 2.11 4.10 1.28 E-07 9.04 E-13
Rv1184c 3 Unknown; possible exported
protein, probable lipase, esterase
or quitinase (43)
4.80 5.00 3.69 E-07 0.024
Rv1733ca 3 Unknown; probable conserved
transmembrane protein
2.77 1.50 2.62 E-08 0.012
Rv1996a 0 Unknown; universal stress protein
family
1.93 1.19 1.09 E-12 6.27 E-06
Rv2794c pptT 1 4=-Phosphopantetheinyl transferase 1.18 3.00 0.041 8.33 E-05
Rv3131a 10 Unknown; putative NAD(P)H
nitroreductase
2.89 4.00 1.09 E-12 9.04 E-13
Rv3134ca 10 Unknown; universal stress protein
family
1.03 3.43 5.99 E-06 3.19 E-10
Rv3416 whiB3 9 Redox sensor; transcriptional
regulatory protein
2.50 1.09 0.003 0.009
Rv3612c 10 Unknown 2.00 1.10 0.029 0.014
Rv3614c espD 3 Unknown; ESX-1 secretion
associated protein
2.81 1.50 1.09 E-12 9.04 E-13
Rv3686c 10 Unknown 1.82 3.00 1.60 E-08 3.26 E-07
a Member of the DosR regulon.
b Functional categories based on http://www.tuberculist.epfl.ch: 0, virulence, detoxification, and adaptation; 1, lipid metabolism; 3, cell wall and cell processes; 7, intermediary me-
tabolism and respiration; 9, regulatory proteins; 10, conserved hypothetical proteins.
c RPKM ratio according to phase of growth: exponential (FE/DE) or stationary (FS/DS). The gene is overexpressed in FE or FS if the ratio is1. See Table S1A and B in the
supplemental material for the complete set of data.
d Determined by Fisher exact test, in which statistically significant differential expression between two conditions was determined by looking at genes with FDRs of0.05 (see
Materials and Methods for details).
e http://genome.tbdb.org, accessed December 2012.
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activity of M. tuberculosis during the complex period of latency.
The data derived from the use of the LC-FA in vitro model repre-
sent a novel tool suitable for the study of the susceptibility of
M. tuberculosis to drugs during latency from a new perspective.
FIG 4 Features of lipid signature genes. (A) Sequence logo of the lipid signature motif. The nucleotide sequence was determined by performing Gibbs sampling
of the 500 bp upstream of the initiation codon of the lipid signature genes (see Materials and Methods for details). In the representation of the consensus sequence
shown in the graph, the height of each nucleotide indicates the level of conservation. (B) Differential transcription of the whiB3 gene. Artemis view of the reads
mapped to the whiB3 gene under the conditions tested. The blue arrow indicates the orientation of whiB3 transcription. (B.1) Exponential phase: red, dextrose;
purple, LC-FA. (B.2) Stationary phase: green, dextrose; blue, LC-FA. Antisense transcription is identified in the stationary phase of growth in dextrose.
FIG 5 Proposed scenario of M. tuberculosis growth in the fatty acid model. Growth of M. tuberculosis during the in vitro model of even-LC-FA is shown. See the
text (final remarks) for details.
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In summary, our results show a new scenario for the adapta-
tion of M. tuberculosis to a lipid-rich environment, presenting
evidence of the role of reductive stress and giving insights into the
participation of novel molecules such as noncoding RNAs and
tRNAs. These could play important roles in the adaptation of the
bacteria for long-term survival. During the coevolution of the hu-
man host and the tubercle bacilli, these adaptations have probably
been crucial for bacterial survival and the establishment of a bal-
anced coexistence, represented by a successful infection without
disease, which we know as latent TB.
MATERIALS AND METHODS
Bacterial strain and culture conditions. M. tuberculosis H37Rv (donated
by The Pasteur Institute, Paris, France) was grown at 37°C in 100 ml of
Dubos broth (Difco) supplemented with 10% ADC (Middlebrook) in a
1-liter flask to an optical density at 600 nm (OD600) of 0.5. The culture was
divided in two, and cells were pelleted by centrifugation and resuspended
in (i) Dubos broth base (without glycerol) (BD Difco) containing 0.5%
albumin (Sigma Fraction V, fatty acid free) and supplemented with a
mixture of 0.003% FA with even an number of carbon atoms (0.001%
each oleic [18 carbon atoms], palmitic [16 carbon atoms], and stearic [18
carbon atoms] acids) or (ii) Dubos medium with 0.5% albumin– 0.75%
dextrose– 0.04% catalase (ADC enrichment). Cultures were grown with
agitation at 200 rpm at 37°C, and growth was monitored by measuring the
OD600.
RNA isolation. Total RNA was isolated from cultures in the exponen-
tial and stationary phases as previously described (51). Basically, cultures
were harvested by centrifugation and pellets were resuspended in guani-
dinium chloride buffer (6 M guanidinium chloride, 0.1% Tween 80,
1 mM 2-mercaptoethanol, 10 mM EDTA) in a proportion of 1 ml of
buffer/100 ml of culture. Cells were lysed mechanically in a FastPrep
(Thermo Scientific) with 150- to 200-m glass beads (Sigma-Aldrich) by
performing four lysis cycles of 15 s each at high speed (6.5 m/s). Nucleic
acids were purified with phenol-chloroform-isoamyl alcohol (25:24:1),
and RNA was differentially precipitated with 0.4 volume of absolute eth-
anol (added drop by drop). Finally, RNA was washed three times with
Trizol reagent (Invitrogen). RNA integrity was analyzed with a bioana-
lyzer (Agilent Technologies) and quantified by spectrophotometry with
the NanoDrop ND-1000 (Thermo Scientific).
Library preparation and sequencing. Strand-specific RNA-seq li-
braries were prepared in accordance with the protocol described by Wald-
bauer and coworkers (52). Briefly, The DNase-treated RNA (100 ng) was
fragmented by divalent-cation hydrolysis (Fragmentation Buffer; Am-
bion, Austin, TX) at 70°C for 12 min to yield fragment sizes between 50
and 300 nt. After precipitation with ethanol, fragments were subjected to
poly(A) tailing and end repairing (NEB Reagents). RNA was treated with
Antarctic phosphatase (New England Biolabs) and then phosphorylated
at the 5= RNA end with T4 polynucleotide kinase. The transcribing strand
was labeled by ligation of a 5= hybrid DNA-RNA primer and after purifi-
cation with RNA clean XP beads (Beckman Coulter Genomics), the first-
strand cDNA synthesis reaction was carried out with SuperScript II re-
verse transcriptase (Invitrogen) and Illumina’s poly(T) primer and
deoxynucleoside triphosphates (20 mM). Reaction components were re-
moved with Agencourt AMPure XP SPRI beads (Beckman), and primary
transcripts were enriched with Pfu Hi Fidelity polymerase (Invitrogen)
and the Illumina spacers as primers. Illumina adaptors and bar codes were
ligated by PCR in accordance with the manufacturer’s instructions. Li-
braries were purified with SPRI beads (Beckman) and quantified with a
NanoDrop (Bio-Rad). Sequencing was performed with the Illumina tech-
nology at Ambry Genetics.
RNA-seq data analysis. Sequence reads were processed to remove
poly(A) and spacer sequences, and only those with quality scores of30
(Illumina 1.3) and a minimal length of 50 bases were used for analysis.
Assessment of read quality was done with the FASTX toolkit v. 0.0.13
(http://hannonlab.cshl.edu/fastx_toolkit/index.html). The reads were
mapped against the M. tuberculosis H37Rv reference genome (accession
no. NC000962.2) with Bow tie v. 0.12.7 (53) and visualized with the Ar-
temis sequence visualization and annotation tool (54). Reads that mapped
to more than one site where excluded. For the analysis, only those reads
for which 50% of the sequence length fell within the annotated ORF were
considered part of the ORF. For the identification of novel expressed IGRs
in the transcriptome, clean reads were analyzed with an in-house algo-
rithm that identifies genomic regions with a minimum depth of 10 reads
and a minimum length of 50 nt. These zones were then annotated by
comparison with the reference genome, with annotation coming from
literature and the TubercuList database (http://www.tuberculist.epfl.ch).
For example, transcripts are annotated as novel intergenic if they show
expression according to the criteria mentioned and they do not overlap
any previously annotated feature in the genome.
Measurement of drug activity. The activity of a drug mixture contain-
ing rifampin (R), moxifloxacin (MX), metronidazole (MZ) and amikacin
(AK) against exponential- and stationary-phase cultures ofM. tuberculosis
grown in dextrose or FA medium was tested. R, MZ, and AK were pur-
chased from Sigma Chemicals (United States); MX was obtained from
Bayer (Mexico). R was dissolved in ethanol; MZ, AK, and MX were dis-
solved in distilled water. To determine drug activity, 4- to 6-day-old
(exponential-phase) cultures and 15-day-old (stationary-phase) cultures
(containing at least 1 106 CFU/ml) were incubated with the drug com-
bination for 0, 7, 14, or 21 days; R, MX, MZ, and AK were used at their
maximum drug concentration in serum at 8, 4, 8, and 8 g/ml, respec-
tively (39). After incubation, culture CFU counts per milliliter were de-
termined by plating appropriate dilutions as described previously (55). In
parallel, 1 ml of each culture was taken to perform 101 to 103 dilutions
with Dubos broth. One milliliter of every dilution was transferred to each
of three tubes containing 9 ml of Dubos broth with or without the fatty
acid mixture, accordingly. These broth cultures were examined for visible
turbidity every 7 days over a 3-week period of incubation at 37°C. The
most probable number (MPN) of viable bacilli was then estimated while
taking in account the patterns of positive and negative tubes (http://www
.fda.gov/food/foodscienceresearch/laboratorymethods/ucm109656.htm;
accessed January 2013). Plating of different culture samples on blood agar
medium showed the absence of bacteria other than mycobacteria. Growth
ofM. tuberculosis in turbid tubes was confirmed by Ziehl-Neelsen staining
and colonial morphology on Middlebrook 7H11
Analysis of the upstream regions of the genes belonged to the lipid
signature. For each gene, 500 nt were taken upstream of the initiation
codon. These regions were fed into the Gibbs sampling algorithm, and the
sequences were analyzed to detect any possible bias in their composition.
This was done by means of the program “unifiedcpp.” Once corrected for
possible bias, the samples were run with the following parameters: k-mer,
12 to 24 nt; -n, for nucleic acid alphabet; -E 3, maximum number of sites
to find; -S 20, number of seeds to try; -i 1,000, number of iterations. The
probability of the motif arising by chance was determined by means of the
hypergeometric distribution (56). For this, the number of genes in which
the motif was present in the 500-nt upstream region in H37Rv was calcu-
lated. It turned out that 767 of the 4,060 genes had the motif (this is the
population distribution), so we wanted to calculate the probability of
drawing 12 out of 14 genes given the population distribution (767/4,060).
qRT-PCR of selected genes. The total transcripts of selected genes
were measured by real-time qRT-PCR. Quantification was performed
with gene-specific primers (see Table S5) and SYBR green (Molecular
Probes, Inc.). Samples were subjected to 40 cycles of amplification (dena-
turation at 95°C for 30 s, specific annealing temperature for 15 s, and
extension at 72°C for 15 s) with a final extension at 72°C for 5 min. To
ensure that the fluorescence levels detected were due to the amplification
of a specific product, a melting curve analysis was performed. Absolute
analysis was carried out. To do this, a standard curve was obtained for each
set of primers by using 10-fold dilutions of known amounts of M. tuber-
culosisH37RV chromosomal DNA (1,000, 10,000, 100,000, and 1,000,000
theoretical copies). Threshold cycle values of each RNA quantitation were
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interpolated to standard curve to obtain gene expression (number of gene
copies per microliter). Normalization of these data was performed by
using 16S rRNA expression levels.
Transmission electron microscopy. Cells were harvested by centrif-
ugation at 16,000 g, washed in sterile phosphate-buffered saline (PBS),
and fixed in 2.5% (vol/vol) glutaraldehyde– 0.1 M sodium phosphate for
1 h. Cells were recovered and resuspended in 1% (wt/vol) osmium tetrox-
ide for 1 h. Cells were then dehydrated through treatment with a series of
ethanol solutions (30, 40, 50, 60, 70, 80, and 90%); each treatment was
performed twice for 10 min each time. A final dehydration step was done
twice with 100% ethanol for 15 min. Samples were embedded in EPON
812 resin (EMS). This resin was polymerized at 60°C for 24 h. Resin blocks
were cut in a Leica Ultracut UCT Ultratome to a 70-nm thickness, placed
on 200-mesh copper grids (EMS), and stained with 30% (wt/vol) uranyl
acetate–70% (vol/vol) methanol and counterstained with Reynolds lead
citrate buffer. Samples were examined with a JEOL JEM-1010 transmis-
sion electron microscope with an acceleration voltage of 60 kV.
Statistical analysis. Statistical analysis for differential gene expression
was evaluated by using RPKMs as expression values and Fisher’s exact test
on a two-by-two contingency table (57) on a per-gene basis in which the
two columns of the table were separated by reads that overlap the gene’s
ORF and reads that do not overlap the ORF, and the two rows were
separated by the two compared samples (FE versus DE or FS versus DS).
Significant differences were determined with Fisher’s exact test with the
additional criteria of a false-discovery rate (FDR) of 5%. The results
were consistent with those obtained with the DEGseq package for biolog-
ical replicates (58).
Nucleotide sequence accession number. The RNA-seq data sets have
been deposited in the NCBI Gene Expression Omnibus (59) under acces-
sion number GSE47863.
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